Sort
141,003 grants matching “cytokine”
A Phase II Evaluation of the Safety and Protective Efficacy of the Live Attenuated Tetravalent Dengue Vaccine TetraVax-DV with Challenge by the Recombinant DENV-2 Virus in a Dengue Endemic Population
$1,249,406Beth Diane Kirkpatrick · University Of Vermont & St Agric College · U01 · FY2023 · AI
Transplant Arteriosclerosis: Viral and Host Mechanism
$1,249,305Stanford University · P01 · FY2001 · AI
Cellular and Developmental Biology of Coxiella burnetii
$1,249,247Robert A Heinzen · Niaid Extramural Activities · Z01 · FY2007 · AI
RAGE and Mechanisms of Vascular Dysfunction
$1,249,231Columbia University Health Sciences · P01 · FY2004 · HL
Signaling in Airway Inflammation
$1,249,085Allan R. Brasier · University Of Texas Med Br Galveston · P01 · FY2007 · AI
Multiscale Analysis of Immune Responses
$1,248,975Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Epigenetic Regulation of T cell differentiation
$1,248,881Keji Zhao · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Development of a novel anti-neuroinflammatory experimental therapeutic for epilepsy and Alzheimer's risk
$1,248,699Victor Shifrin · Immunochem Therapeutics, Llc · R44 · FY2024 · AG
HIV-1 SHEDDING FROM FEMALE GENITAL TRACT
$1,248,693University Of Washington · P01 · FY2004 · HD
Restoration of free radical homeostasis: novel therapy of septic shock
$1,248,631Andrew L Salzman · Radikal Therapeutics, Inc. · R44 · FY2016 · GM
Development of a novel adjuvant for vaccine sparing
$1,248,398Sara Lustigman · New York Blood Center · R01 · FY2017 · AI
Tumor Intrinsic and Microenvironmental Mechanisms Driving Drug Combination Efficacy and Resistance in AML
$1,248,330Jeffrey Wallace Tyner · Oregon Health & Science University · U54 · FY2019 · CA
Investigating mammalian innate immune responses to pathogenic fungi
$1,248,202Eric Dang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Animal models of eye diseases
$1,248,149Sheldon Miller · National Eye Institute · ZIA · FY2013 · EY
Development of an Innovative Material for Transcatheter Peripheral Embolization
$1,247,814Ehsan Jabbarzadeh · Obsidio, Inc. · R44 · FY2022 · HL
Allergen-induced extracellular DNA in type 2 immunity
$1,247,804Hirohito Kita · Mayo Clinic Arizona · R01 · FY2025 · AI
Innate inflammatory responses during pulmonary infections
$1,247,742Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
SCOR IN ACUTE LUNG INJURY
$1,247,617University Of Iowa · P50 · FY2002 · HL
ACUTE INFECTION AND EARLY DISEASE RESEARCH NETWORK
$1,247,493Johns Hopkins University · U01 · FY2001 · AI
Epigenetic Therapy for Thoracic Malignancies
$1,247,492David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA
Disappearing gastrointestinal microbiota in epidemic obesity.
$1,247,198Martin J Blaser · New York University School Of Medicine · R01 · FY2012 · DK
GrowthDifferentiation Factors in Organogenesis
$1,246,888Alan Perantoni · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Chinese Herbal Medicine as a Novel Paradigm for Cancer Chemotherapy
$1,246,839Yung-Chi Cheng · Yale University · P01 · FY2014 · CA
Uterine Leiomyoma Research Center Program
$1,246,816Serdar E Bulun · Northwestern University At Chicago · P01 · FY2015 · HD
Mapping the perivascular reticular network in health, aging, and AD
$1,246,362Rupal I. Mehta · Rush University Medical Center · RF1 · FY2023 · AG